ATRS - アンタレス・ファ―マ （Antares Pharma Inc.）

Halozyme announced acquisition of Antares Pharma at $5.60 per share in cash. See why I expect to have a position in HALO stock for at least five more years.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Antares Pharma, Inc. (NasdaqCM: ATRS) to Halozyme Therapeutics, Inc. (NasdaqGS: HALO). Under the terms of the proposed transaction, shareholders of Antares will receive only $5.60 in cash for each share of Antares that they own. KSF is seeking to determine whether this consideration and the process that led to

NEW YORK , April 20, 2022 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. Weiss Law 305 Broadway, 7th Floor New York, NY 10007 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com Antares Pharma, Inc. … Full story available on Benzinga.com

Antares Pharma, Inc. (NASDAQ:ATRS) with the stream of -0.36% also noticed, India Occidental Petroleum Corporation (NYSE:OXY) encountered a rapid change of -0.47% in the last hour of Friday’s trading session. … The post Hot Stock’s Watch List: Antares Pharma, Inc. (NASDAQ:ATRS), Occidental Petroleum Corporation (NYSE:OXY) appeared first on Stocks Equity .

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Vamping stocks: Antares Pharma, Inc. (NASDAQ:ATRS -0.36%), New Oriental Education & Technology Group Inc. (NYSE:EDU -1.77%) appeared first on Stocks Equity .

Halozyme announced acquisition of Antares Pharma at $5.60 per share in cash. See why I expect to have a position in HALO stock for at least five more years.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Antares Pharma, Inc. (NasdaqCM: ATRS) to Halozyme Therapeutics, Inc. (NasdaqGS: HALO). Under the terms of the proposed transaction, shareholders of Antares will receive only $5.60 in cash for each share of Antares that they own. KSF is seeking to determine whether this consideration and the process that led to

NEW YORK , April 20, 2022 /PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. Weiss Law 305 Broadway, 7th Floor New York, NY 10007 (212) 682-3025 (888) 593-4771 stockinfo@weisslawllp.com Antares Pharma, Inc. … Full story available on Benzinga.com

Antares Pharma, Inc. (NASDAQ:ATRS) with the stream of -0.36% also noticed, India Occidental Petroleum Corporation (NYSE:OXY) encountered a rapid change of -0.47% in the last hour of Friday’s trading session. … The post Hot Stock’s Watch List: Antares Pharma, Inc. (NASDAQ:ATRS), Occidental Petroleum Corporation (NYSE:OXY) appeared first on Stocks Equity .

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Vamping stocks: Antares Pharma, Inc. (NASDAQ:ATRS -0.36%), New Oriental Education & Technology Group Inc. (NYSE:EDU -1.77%) appeared first on Stocks Equity .

EWING, N.J., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced that Robert F. Apple, President and Chief Executive Officer, is scheduled to virtually present and host investor meetings at the Cowen 42 nd Annual Healthcare Conference being held on March 7-9, 2022.

During the last session, Antares Pharma Inc. (NASDAQ:ATRS)s traded shares were 0.46 million, with the beta value of the company hitting 1.49. At the end of the trading day, the stocks price was $3.49, reflecting an intraday loss of -2.51% or -$0.09. The 52-week high for the ATRS share is $5.07, that puts it down Antares Pharma Inc. (NASDAQ: ATRS) Is Up 4.18% In A Month. Could There Be Any Hope That It Will Rise Soon? Read More »

EWING, N.J., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the “Company”), a specialty pharmaceutical company, today announced it will release its fourth quarter and full-year 2021 financial and operating results on Thursday, March 3, 2022, before the market opens.

The FDA has accepted a New Drug Application for the oral testosterone replacement therapy Tlando from Antares Pharma.